ESMO 2021: Messenger RNA COVID-19 Vaccine Safe for Patients on Treatment for Solid Tumors
Seroconversion rate was similar to that seen in controls
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Seroconversion rate was similar to that seen in controls
Only registered members have full access to PracticeUpdate content.